Trial-based economic evaluations in occupational health: Principles, methods, and recommendations

Journal of Occupational and Environmental Medicine

Volumn 56, Issue 6, 2014, Pages 563-572

  Van Dongen, Johanna M ^a,b   Van Wier, Marieke F ^a,b   Tompa, Emile ^c,d,e   Bongers, Paulien M ^b,f   Van Der Beek, Allard J ^b   Van Tulder, Maurits W ^a,b   Bosmans, Judith E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE FOR WORK AND HEALTH   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BOOTSTRAPPING; CARDIOVASCULAR DISEASE; CONSTRUCTION WORKER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; FOLLOW UP; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; INFORMATION PROCESSING; METHODOLOGY; OCCUPATIONAL HEALTH; PRODUCTIVITY; SAMPLE SIZE; SELF CONCEPT; SENSITIVITY ANALYSIS; WORKMAN COMPENSATION; ABSENTEEISM; COMPARATIVE EFFECTIVENESS; ECONOMICS; INTENTION TO TREAT ANALYSIS; ORGANIZATION AND MANAGEMENT; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT;

ABSENTEEISM; BENCHMARKING; COMPARATIVE EFFECTIVENESS RESEARCH; EFFICIENCY, ORGANIZATIONAL; HEALTH CARE COSTS; HUMANS; INTENTION TO TREAT ANALYSIS; OCCUPATIONAL HEALTH; PRAGMATIC CLINICAL TRIALS AS TOPIC; RELATIVE VALUE SCALES; WORKERS' COMPENSATION;

EID: 84902287220     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000165     Document Type: Article

References (66)

1. Drummond MF, SculpherMJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford University Press; 2005.
2. BurdorfA. Economic evaluation in occupational health-its goals, challenges, and opportunities. Scand J Work Environ Health. 2007;33:161-164.
3. Tompa E, Verbeek J, van Tulder MW, de Boer A. Developing guidelines for good practice in economic evaluation of occupational health and safety intervention. Scand J Work Environ Health. 2010;36:313-318.
4. Tompa E, Dolinschi R, de Oliveira C. Practice and potential of economic evaluation of workplace-based interventions for occupational health and safety. J Occup Rehabil. 2006;16:367-392.
5. Uegaki K, de Bruijne MC, Lambeek L, et al. Economic evaluations of occupational health interventions from a corporate perspective-A systematic reviewof methodological quality. Scand JWork Environ Health. 2010;36:273-288.
6. van Dongen JM, Proper KI, van Wier MF, et al. Systematic review on the financial return of worksite health promotion programmes aimed at improving nutrition and/or increasing physical activity. Obes Rev. 2011;12:1031-1049.
7. van Dongen JM, Proper KI, van Wier MF, et al. A systematic review of the cost-effectiveness of worksite physical activity and/or nutrition programs. Scand J Work Environ Health. 2012;38:393-408.
8. Tompa E, Culyer AJ, Dolinschi J. Economic Evaluation of Interventions for Occupational Health and Safety: Developing Good Practice. New York: Oxford University Press; 2008.
9. Uegaki K, de Bruijne MC, Anema JR, et al. Consensus-based findings and recommendations for estimating the costs of health-related productivity loss from a company's perspective. Scand J Work Environ Health. 2007;33:122-130.
10. Korthals-de Bos I, van Tulder M, van Dieten H, Bouter L. Economic evaluations and randomized trials in spinal disorders: principles andmethods. Spine. 2004;29:442-448.
11. van Dongen JM, Tompa E, Clune LA, et al. Bridging the gap between the economic evaluation literature and daily practice in occupation health: a qualitative study among decision-makers in the healthcare sector. Implement Sci. 2013;8:57.
12. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluations in Clinical Trials. New York: Oxford University Press; 2007.
13. Ramsey S, Willke R, Briggs A, et al. Good research practices for costeffectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force Report. Value Health. 2005;8:521-533.
14. Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011;342:d1548.
15. Verbeek J, Pulliainen M, Kankaanpaa E. A systematic review of occupational safety and health business cases. Scand JWork Environ Health. 2009;35:403-412.
16. Downey AM, Sharp DJ. Why do managers allocate resources to workplace health promotion programmes in countries with national health coverage? Health Promot Int. 2007;22:102-111.
17. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313:275-283.
18. Goossens M, Rutten-van M̈olken M, Vlaeyen J, van der Linden S. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol. 2000;53:688-695.
19. Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care. 2005;43(suppl):5-14.
20. Frick FD. Microcosting quantity data collection methods. Med Care. 2009;47:S76-S81.
21. Hakkaart-van Roijen L, Tan SS, Bouwmans CAM. Handleiding voor Kostenonderzoek. Methoden en Standaardkostprijzen voor Economische Evaluaties in de Gezondheidszorg. Diemen: College voor zorgverzekeringen; 2010.
22. Zhang W, Bansback N, Anis AH. Measuring and valuing productivity loss due to poor health: a critical review. Soc Sci Med. 2011;72:185-192.
23. Krol M, Brouwer WBF, Rutten FFH. Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics. 2013;31:537-549.
24. Koopmanschap MA, Rutten FFH. Indirect costs in economic studies: confronting the confusion. PharmacoEconomics. 1993;4:446-454.
25. Koopmanschap MA, Rutten FFH, van Ineveld BM, Van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14:171-189.
26. Kessler RC, Barber C, Beck A, Berglund P, Cleary PD, McKenas D. The World Health Organization health and work performance questionnaire (HPQ). J Occup Environ Med. 2003;45:156-174.
27. Kessler RC, Ames M, Hymel PA, Loeppke R, McKenas DK, Richling DE. Using the World Health Organization Health and Work Performance Questionnaire (HPQ) to evaluate the indirect workplace costs of illness. J Occup Environ Med. 2004;46:S23-S37.
28. KoopmanschapMA. PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Rev PharmacoeconOutcomes Res. 2005;5:23-28.
29. Van Roijen L, Essink-bot ML, Koopmanschap MA, Bonsel G, Rutten FFH. Labor and health status in economic evaluation of health care: The Health and Labor Questionnaire. Int J Technol Assess Health Care. 1996;12:405-415.
30. Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I. Validity of a Work Productivity and Activity Impairment Questionnaire for Patients with Symptoms of Gastro-Esophageal Reflux Disease (WPAI-GERD)-results from a cross-sectional study. Value Health. 2002;5:106-113.
31. Reilly MC, Bracco A, Ricci JF, Santoro J, Stevens T. The validity and accuracy of the Work Productivity and Activity Impairment Questionnaire- Irritable Bowel Syndrome Version (WPAI:IBS). Aliment Pharmacol Ther. 2004;20:459-467.
32. Prasad M, Wahlqvist P, Shikiar R, Shih YT. A review of self-report instruments measuring health-related work productivity. Pharmacoeconomics. 2004;22:225-244.
33. NICE. Guide to the methods of technology appraisal. Available at: http: //www. nice. org. uk/media/B52/A7/TAMethodsGuideUpdatedJune2008. pdf. Accessed January 11, 2013.
34. Hamberg-van Reenen HH, Proper KI, van den Berg M. Worksite mental health interventions: a systematic review of economic evaluations. Occup Environ Med. 2012;69:837-845.
35. Brazier J, Deverill M, Green C, Harper R, Booth A. A review of the use of health status measures in economic evaluation. J Health Serv Res Policy. 1999;4:174-184.
36. Uegaki K. Economic Evaluation of Interventions for Occupational Health. Amsterdam: Vrije Universiteit Amsterdam 2010.
37. Eysink PED, Hamberg-van Reenen HH, van Gool CH, Hoeymans N, Burdorf A. Meten van verloren arbeidsjaren door ziekte: Disease-Adjusted Working Years (DAWYs): Verkenning van een Nieuwe Maat. Bilthoven: RIVM; 2010.
38. Groeneveld IF, van Wier MF, Proper K, Bosmans JE, Van Mechelen W, van der Beek A. Cost-effectiveness and cost-benefit of a lifestyle intervention for workers in the construction industry at risk for cardiovascular disease. J Occup Environ Med. 2011;53:610-617.
39. Briggs AH, Gray AM. Power and sample size calculations for stochastic cost-effectiveness analysis. Med Decis Making. 1998;18:S81-S92.
40. Gafni A, Walter SD, Birch S, Sendi P. An opportunity cost approach to sample size calculation in cost-effectiveness analysis. Health Econ. 2008;17: 99-107.
41. Gardiner JC, Sirbu CM, Rahbar MH. Update on statistical power and sample size assessments for cost-effectiveness studies. Expert Rev Pharmacoeconomics Outcomes Res. 2004;4:89-98.
42. Al MJ, Van Hout BA, Michel BC, Rutten FFH. Sample size calculation in economic evaluations. Health Econ. 1998;7:327-335.
43. Andrew B. Economic evaluation and clinical trials: size matters. BMJ. 2000;321:1362-1363.
44. Goossens M, Evers S, Vlaeyen J, Rutten-van M̈olken M, van der Linden S. Principles of economic evaluation for interventions of chronic musculoskeletal pain. Eur J Pain. 1999;3:343-353.
45. Moher D, Hopewell S, Schultz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.
46. Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
47. Noble SM, Hollingworth W, Tilling K. Missing data in trial-based costeffectiveness analysis: the current state of play. Health Econ. 2012;21:187-200.
48. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Statist Med. 2011;30:377-399.
49. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley &Sons; 1987.
50. Simon GT, Julie AB. How should cost data in pragmatic randomised trials be analysed? BMJ. 2000;320:1197-1200.
51. Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. StatistMed. 2000;19:3219-3236.
52. Chaudhary MA, Stearns SC. Estimating confidence intervals for costeffectiveness ratios: an example from a randomized trial. Statist Med. 1996;15:1447-1458.
53. Kelley K. The effects of nonnormal distributions on confidence intervals around the standardized mean difference: bootstrap and parametric confidence intervals. Educ Psychol Meas. 2005;65:51-69.
54. Black WC. The CE plane: a graphic representation of cost-effectiveness. Med Decis Making. 1990;10:212-214.
55. Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Ann Rev Public Health. 2002;23:377-401.
56. Fenwick E, Marshall D, Levy A, Nichol G. Using and interpreting costeffectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res. 2006;6:52.
57. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves-facts, fallacies and frequently asked questions. Health Econ. 2004;13:405-415.
58. Phillips JJ. Return on Investment in Training and Performance Improvement Programs. Burlington: Elsevier; 2003.
59. Stone PW. Return-on-investment models. Appl Nurs Res. 2005;18:186-189.
60. Giffin SC. Dealing With Uncertainty in the Economic Evaluation of Health care Technologies. PhD Dissertation; 2010.
61. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of healthcare technologies: the role of sensitivity analysis. Health Econ. 1994;3:95-104.
62. Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005;14:339-347.
63. Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. New York: Oxford University Press; 2006.
64. Dehejia RH, Wahba S. Propensity score-matching methods for nonexperimental causal studies. Rev Econ Stat. 2002;84:151-161.
65. Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv. 2008;22:31-72.
66. Verbeek J, Pulliainen M, Kankaanpaa E, Taimela S. Transferring results of occupational safety and health cost-effectiveness studies from one country to another-A case study. Scand J Work Environ Health. 2010;36:305-312.